Letter to the Editor
In the study “Implementing Symptom Management Follow-up Using an Electronic Patient-Reported Outcome Platform in Outpatients With Advanced Cancer: Longitudinal Single-Center Prospective Study,” Tang et al  suggest that using an electronic patient-reported outcome (ePRO) platform for following up on symptom management in patients with advanced cancer can improve completion rates and decrease the number of dropouts.
Tang et al  reported a high average compliance rate of 80.3% for all 8 out-of-hospital follow-up studies. Despite two reminders plus phone calls to patients who had not responded, 14 patients rejected participation in the follow-ups and 19 patients could not be contacted, resulting in about 20% of participants dropping out. According to a study by Lee et al [ ], a decrease in engagement is related to the usefulness of an app for the continuous user. Chiu et al [ ] also stated that user satisfaction is related to commitment. We believe that integrating these findings would lead to higher compliance in accepting the usability of an app and maintaining user satisfaction. Moreover, Lee et al [ ] found that user satisfaction with utility is related to patient compliance with ePRO use. Therefore, user-friendly and attractive design is crucial for increasing satisfaction [ ], especially for older adults. Apps should be equipped with not only new technologies but also interface designs that conform to the skills of older adults [ ]. Therefore, we suggest evaluating the usefulness of an ePRO platform to determine user satisfaction, improve the user interface system, and reduce the dropout rate.
We would like to thank Enago for the English language editing.
Conflicts of Interest
The corresponding author of “Implementing Symptom Management Follow-up Using an Electronic Patient-Reported Outcome Platform in Outpatients With Advanced Cancer: Longitudinal Single-Center Prospective Study” did not provide a response to this letter.
- Tang L, He Y, Pang Y, Su Z, Li J, Zhang Y, et al. Implementing symptom management follow-up using an electronic patient-reported outcome platform in outpatients with advanced cancer: longitudinal single-center prospective study. JMIR Form Res 2022 May 10;6(5):e21458 [https://formative.jmir.org/2022/5/e21458/] [CrossRef] [Medline]
- Lee K, Kwon H, Lee B, Lee G, Lee JH, Park YR, et al. Effect of self-monitoring on long-term patient engagement with mobile health applications. PLoS One 2018;13(7):e0201166 [https://dx.plos.org/10.1371/journal.pone.0201166] [CrossRef] [Medline]
- Chiu W, Cho H, Chi C. Consumers' continuance intention to use fitness and health apps: an integration of the expectation–confirmation model and investment model. Inf Technol People 2020 Jun 26;34(3):978-998 [CrossRef]
- Lee M, Kang D, Kim S, Lim J, Yoon J, Kim Y, et al. Who is more likely to adopt and comply with the electronic patient-reported outcome measure (ePROM) mobile application? A real-world study with cancer patients undergoing active treatment. Support Care Cancer 2022 Jan;30(1):659-668 [CrossRef] [Medline]
- Kim D, Lee Y, Oh J, Seo D, Lee K, Kim Y, et al. Effects of patient-generated health data: comparison of two versions of long-term mobile personal health record usage logs. Healthcare (Basel) 2021 Dec 28;10(1):53 [https://www.mdpi.com/resolver?pii=healthcare10010053] [CrossRef] [Medline]
|ePRO: electronic patient-reported outcome|
Edited by T Leung; This is a non–peer-reviewed article. submitted 24.08.22; accepted 27.07.23; published 07.08.23Copyright
©Yu Haniuda, Michihiro Tsubaki, Yoshiyasu Ito. Originally published in JMIR Formative Research (https://formative.jmir.org), 07.08.2023.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.